Open AccessIs it possible to use riamilovir to prevent infection and treat COVID-19?
Author(s) -
V.M. Tsvetov Tsvetov,
К. Б. Мирзаев,
Д. А. Сычёв
Publication year - 2020
Publication title -
kačestvennaâ kliničeskaâ praktika
Language(s) - English
Resource type - Journals
eISSN - 2618-8473
pISSN - 2588-0519
DOI - 10.37489/2588-0519-2020-s4-15-17
Subject(s) - covid-19 , medicine , intensive care medicine , clinical trial , pneumonia , coronavirus infections , virology , outbreak , infectious disease (medical specialty) , disease
Routine clinical use of riamilovir in COVID-19 is not recommended. The use of riamilovir is possible in clinical trials.